Annexon (ANNX) Misses Q2 Earnings Expectations
Annexon (NASDAQ:ANNX) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Annexon (NASDAQ:ANNX) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Amazon.com, Inc. (NASDAQ:AMZN) during Q2 2026, according to its most recent 13F filing with the…
Read moreAvalyn Pharma (NASDAQ:AVLN) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Microsoft Corporation (NASDAQ:MSFT) during Q2 2026, according to its most recent 13F filing with the…
Read moreUnicycive Therapeutics (NASDAQ:UNCY) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Apple Inc. (NASDAQ:AAPL) during Q2 2026, according to its most recent 13F filing with the Securities and…
Read moreCNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in NVIDIA Corporation (NASDAQ:NVDA) during Q2 2026, according to its most recent 13F filing with the…
Read moreXilio Therapeutics (NASDAQ:XLO) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreLexeo Therapeutics (NASDAQ:LXEO) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreCentury Therapeutics (NASDAQ:IPSC) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreTScan Therapeutics (NASDAQ:TCRX) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read morePharvaris (NASDAQ:PHVS) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreAdagene (NASDAQ:ADAG) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreSutro Biopharma (NASDAQ:STRO) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreBio-Techne (NASDAQ:TECH) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreIOYY (NASDAQ:IOYY) will go ex-dividend tomorrow, August 07, 2026.
Read moreAZYY (NASDAQ:AZYY) will go ex-dividend tomorrow, August 07, 2026.
Read moreHOYY (NASDAQ:HOYY) will go ex-dividend tomorrow, August 07, 2026.
Read morePLYY (NASDAQ:PLYY) will go ex-dividend tomorrow, August 07, 2026.
Read more